Health Care Archives - Page 39 of 478

2 minute read

Once Valued At Billions, 23andMe’s CEO Considers Privatization To Secure Company’s Future

April 18, 12:06 PM

Anne Wojcicki, CEO of 23andMe mulls taking the genetics company private amid market challenges. With declining revenue and a focus shift to drug development, the move seeks funding for potential breakthroughs.

GSK

2 minute read

FDA Classifies Boston Scientific’s Recall For Device To Stop Blood Flow As ‘Most Serious’

By Vandana Singh

April 18, 10:02 AM

Boston Scientific announces a Class I recall of Obsidio Embolic due to high-risk implications for lower GI bleeding embolization. Potential adverse effects include bowel ischemia, necessitating major surgery or resulting in prolonged hospitalization.

AXNX

2 minute read

Elevance Health Clocks $2.2B Q1 Net Profit Despite 21% Drop In Medicaid Enrollment, Lifts Annual Guidance

By Vandana Singh

April 18, 9:58 AM

Elevance Health reports Q1 revenues at $42.3 billion, surpassing expectations. CEO Gail Boudreaux highlights strategic growth initiatives, with profit up 12.2% Y/Y and adjusted EPS at $10.64. Medicaid membership decline offset by commercial and ACA enrollment.

ELV

2 minute read

Analysts Raises Forecasts On UnitedHealth On Controlled Growth Strategy After Cyber Hack

By Vandana Singh

April 17, 3:54 PM

UnitedHealth reports robust Q1 results despite cybersecurity challenges. Revenue exceeds $99.8 billion, with adjusted EPS of $6.91, surpassing expectations. Analysts upbeat, Piper Sandler raises price target to $571, while Truist maintains Buy with $600 target.

UNH

2 minute read

Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future

By Vandana Singh

April 17, 3:37 PM

Johnson & Johnson reports first-quarter earnings, with adjusted EPS up 12.4% and sales up 2.3%. Analysts optimistic about stock's future, highlighting potential growth from new drug approvals. JNJ aims to lead in Innovative Medicines and MedTech.

JNJ

2 minute read

Is Your Botox Real Or Fake? Counterfeit Boxes Circulate For Widely Used Antiwrinkle Treatment, CDC And FDA Investigate Harmful Reactions

By Vandana Singh

April 17, 2:42 PM

Be cautious of counterfeit Botox for cosmetic use. FDA warns of adverse reactions in multiple states. Symptoms include vision issues, difficulty breathing, and weakness. Ensure authenticity before use.

ABBV

2 minute read

Amgen/AstraZeneca’s Asthma Drug Tezspire Vs. Sanofi/Regeneron’s Blockbuster Dupixent – Analyst Gives His Pick

By Vandana Singh

April 17, 2:39 PM

Amgen's Tezspire shows promising COPD trial results and potential market expansion beyond asthma. Comparison with Dupixent reveals significant benefits for eosinophil counts ≥150 cells/μL and ≥300 cells/μL.

AMGN

1 minute read

Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson’s Data

By Vandana Singh

April 17, 12:41 PM

Sage Therapeutics' Phase 2 study on dalzanemdor (SAGE-718) for mild cognitive impairment in Parkinson's Disease. Learn about topline results, safety, and future milestones in 2024.

SAGE

2 minute read

Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak’s Takeover Bid Valued Up To $7.75/Share

By Vandana Singh

April 17, 12:29 PM

Vanda Pharmaceuticals rebuffs unsolicited proposals from Future Pak LLC, citing undervaluation. Offers up to $7.75 per share. Board asserts resilient business with FDA-approved products. Future Pak urged to reconsider terms for fair shareholder value.

VNDA

2 minute read

Novartis Multiple Sclerosis Drug Kesimpta Shows Substantial Benefit Of Up To 6 Years

By Vandana Singh

April 17, 11:48 AM

Sustained efficacy with Novartis' Kesimpta for up to 6 years in recently diagnosed relapsing multiple sclerosis. Significant reductions in relapses, MRI lesions, and disability worsening observed.

NVS